Delos Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Delos Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $3,610 - $3,973	4 Added 200.0%	6 $5,000
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $40,309 - $45,848	-52 Reduced 96.3%	2 $1,000
Q3 2022 Nov 15, 2022	BUY	$573.97 - $724.32 $1,147 - $1,448	2 Added 3.85%	54 $37,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $28,260 - $34,890	52 New	52 $33,000

1,529

82.7M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Delos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Delos Wealth Advisors, LLC with notifications on news.